NeueHealthNEUE
NEUE
About: NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
Employees: 986
0
Funds holding %
of 7,202 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 38 [Q4 2024] → 39 (+1) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 5 [Q4 2024] → 5 (+0) [Q1 2025]
2.47% less ownership
Funds ownership: 63.64% [Q4 2024] → 61.16% (-2.47%) [Q1 2025]
8% less capital invested
Capital invested by funds: $39M [Q4 2024] → $35.9M (-$3.06M) [Q1 2025]
78% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 9
Research analyst outlook
We haven’t received any recent analyst ratings for NEUE.
Financial journalist opinion
Based on 3 articles about NEUE published over the past 30 days
Neutral
Seeking Alpha
1 week ago
NeueHealth, Inc (NEUE) Q1 2025 Earnings Call Transcript
NeueHealth, Inc (NYSE:NEUE ) Q1 2025 Results Conference Call May 8, 2025 8:00 AM ET Company Participants Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and welcome to NeueHealth's First Quarter 2025 Earnings Conference Call. As a reminder, this call is being recorded.
Neutral
Business Wire
1 week ago
NeueHealth Reports First Quarter 2025 Results
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. “We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another quarter of Adjusted EBITDA profitability,” said Mike Mikan, President and CEO of NeueHealth. “Our value-driven, consumer-centric care model is compelling,.
Neutral
Business Wire
3 weeks ago
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number,.
Neutral
Business Wire
1 month ago
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NeueHealth, Inc. (NYSE: NEUE) to an affiliate of New Enterprise Associates. Under the terms of the proposed transaction, shareholders of NeueHealth will receive $7.33 in cash for each share of NeueHealth that they own. KSF is seeking to determine whether this consideration and the process that led to it are ad.
Neutral
Seeking Alpha
1 month ago
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
NeueHealth, Inc (NYSE:NEUE ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and thank you for joining us for the NeueHealth Q4 2024 Earnings Conference Call. My name is Carlin.
Neutral
Business Wire
2 months ago
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. “In 2024, we delivered our strongest financial performance to date, demonstrating the power of our value-driven, consumer-centric care model,” said Mike Mikan, President and CEO of NeueHealth. “We have established a strong foundation to drive strategic growth in 2025 with a.
Neutral
Business Wire
2 months ago
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report fourth quarter and full year 2024 financial results before the financial markets open on Thursday, March 20, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, in.
Neutral
PRNewsWire
3 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into NeueHealth Inc. ("NEUE").
NEW YORK , Feb. 11, 2025 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own NeueHealth Inc. ("NEUE" or the "Company") (NYSE: NEUE) stock purchased on or before December 22 , 2024 . Levi & Korsinsky, LLP has commenced an investigation into potential breaches of fiduciary duty by the NEUE board of directors.
Neutral
PRNewsWire
3 months ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEUE, ESSA, LTRPA on Behalf of Shareholders
NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: NeueHealth, Inc. (NYSE: NEUE)'s sale to an affiliate of New Enterprise Associates for $7.33 per share in cash. If you are a NeueHealth shareholder, click here to learn more about your rights and options.
Neutral
Accesswire
3 months ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
Charts implemented using Lightweight Charts™